These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28521879)

  • 1. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.
    Villa M; Parravano M; Micheli A; Gaddini L; Matteucci A; Mallozzi C; Facchiano F; Malchiodi-Albedi F; Pricci F
    Metabolism; 2017 Jun; 71():64-69. PubMed ID: 28521879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
    Pugliese G; Pricci F; Leto G; Amadio L; Iacobini C; Romeo G; Lenti L; Sale P; Gradini R; Liu FT; Di Mario U
    Diabetes; 2000 Jul; 49(7):1249-57. PubMed ID: 10909985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains.
    Gugliucci A; Menini T
    Life Sci; 1998; 62(23):2141-50. PubMed ID: 9627093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
    Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
    Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation.
    Leto G; Pricci F; Amadio L; Iacobini C; Cordone S; Diaz-Horta O; Romeo G; Barsotti P; Rotella CM; di Mario U; Pugliese G
    Diabetes Metab Res Rev; 2001; 17(6):448-58. PubMed ID: 11757081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats.
    Tanaka Y; Uchino H; Shimizu T; Yoshii H; Niwa M; Ohmura C; Mitsuhashi N; Onuma T; Kawamori R
    Eur J Pharmacol; 1999 Jul; 376(1-2):17-22. PubMed ID: 10440084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.
    Stitt AW; Li YM; Gardiner TA; Bucala R; Archer DB; Vlassara H
    Am J Pathol; 1997 Feb; 150(2):523-31. PubMed ID: 9033268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control.
    Turk Z; Misur I; Turk N; Benko B
    Clin Chem Lab Med; 1999 Aug; 37(8):813-20. PubMed ID: 10536930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histones from diabetic rats contain increased levels of advanced glycation end products.
    Gugliucci A; Bendayan M
    Biochem Biophys Res Commun; 1995 Jul; 212(1):56-62. PubMed ID: 7612018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of advanced glycation endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: an ultrastructural study using colloidal gold cytochemistry.
    Gugliucci A; Bendayan M
    J Histochem Cytochem; 1995 Jun; 43(6):591-600. PubMed ID: 7769229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo.
    Bonnardel-Phu E; Wautier JL; Schmidt AM; Avila C; Vicaut E
    Diabetes; 1999 Oct; 48(10):2052-8. PubMed ID: 10512373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
    Ido Y; Kilo C; Williamson JR
    Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E; Soulis T; Boel E; Cooper ME; Rees S
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Rates of Glycation Following Exposure to Unique Monosaccharides.
    Clarke DM; Koutnik AP; Johnson RJ; DeBlasi JM; Bikman BT; Arroyo JA; Reynolds PR
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
    Stitt A; Gardiner TA; Alderson NL; Canning P; Frizzell N; Duffy N; Boyle C; Januszewski AS; Chachich M; Baynes JW; Thorpe SR
    Diabetes; 2002 Sep; 51(9):2826-32. PubMed ID: 12196477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth modulation of retinal microvascular cells by early and advanced glycation products.
    Ruggiero-Lopez D; Rellier N; Lecomte M; Lagarde M; Wiernsperger N
    Diabetes Res Clin Pract; 1997 Jan; 34(3):135-42. PubMed ID: 9069564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.